Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.
Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.
PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.
Zhenyu (Henry) Huang acts as guest editor in an upcoming special issue on “Climate Change Mitigation and Adaptation in Power and Energy Systems." The special edition is published by Elsevier.
The Joint Appointment program at PNNL is one of the most diverse among other U.S. national laboratories, involving nearly 60 universities and research institutions in the United States and abroad.
New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.
Grid Forward, an industry association dedicated to promoting and accelerating innovation in the regional electric system, honored PNNL's Carl Imhoff with the 2021 Grid Innovator Award.
PNNL has released the first version of ExaGO, an open-source grid modeling software that can take advantage of emerging heterogeneous computing architecture to help grid operators plan ahead for extreme events.